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me disease is the most common vector-borne illness in the United States and is increasingly recognized as a source of significant human morbidity due to the secondary and tertiary complications of cardiac, neurologic, and rheumatic involvement (1) . Among inbred strains of mice experimentally infected with Borrelia burgdorferi, the severity of arthritis is under host genetic control, with BALB/c mice developing only mild disease but C3H/HeJ mice acquiring severe arthritis (2, 3) . Severity has been linked to higher spirochete burdens (4) , suggesting that susceptibility to pathology represents a deficiency in microbial immunity. In a number of infectious disease models with varying genetic susceptibility, polarized lymphokine responses underlie the discordance in disease outcome (5) (6) (7) . Direct evidence for a difference in the T helper subsets that susceptible and resistant hosts mount in response to/~ burgdorferi has been lacking.
To examine the development of T helper cell subsets in experimental Lyme borreliosis, we inoculated the spirochete in BALB/c and C3H/HeJ mice in a manner that would allow removal of a draining lymph node that had focused the immune response to the microbial depot. In addition to characterizing the phenotype of Thl and Th2 cytokines produced during differential disease responses, we have neutralized IL-4 and IFN-~/in vivo to ascribe a causal relationship between the type of T helper cell response and the genetic basis for susceptibility to Lyme disease.
Materials and Methods
Animals and Bacteria. Female Cytokine Neutralization. 1 mg of 11Bll (rat anti-mouse Ib4) or XMG 1.2 (rat anti-mouse IFN-3') antibody was administered intraperitoneally on the day of infection and in some cases doses were repeated weekly or twice weekly for 2 wk. (Fig. 2 B) . In most instances there was little, if any, production of antigen-specific IL-4 or IFN-% When production did exceed background levels, it was usually manifest as slightly higher IFN-3~ production by C3H/HeJ mice with no difference in Ib4 production between strains.
Results

Proximal Arthritis with Genetic Variability Develops after
Cytokine Neutralization Alters Disease Phenotype. To establish whether the observed differences in cytokine production influence the course of infection, we treated C3H/HeJ mice with anti-IFN-3, and BALB/c mice with anti-Ib4 mAbs once or repeatedly at the initiation of infection (Fig. 3) . There was marked reversal in disease phenotype in the course of early arthritis when these two interventions were made regardless of the number of doses given (data not shown). Treated C3H/HeJ mice developed much milder arthritis at a time when severity had peaked in untreated animals and treated BALB/c mice developed peak severity far greater than untreated animals, often approximating susceptible C3H/HeJ mice.
Discussion
Infection of BALB/c and C3H/HeJ mice with/~ burgdorJer/has proven a useful model in illustrating a genetic basis for susceptibility to Lyme disease (2-4) although immunologic mechanisms for the observed differences have been obscure. In several infectious disease models that exhibit differential susceptibility, the immunologic mechanism underlying disease phenotype has been the type of T helper cell response (Thl versus Th2) mounted against the invading pathogen (5-7). In a study of four humans with chronic Lyme disease, T cell dones exhibited an exclusively Thl phenotype (8) . Susceptible C3H/HeJ have higher levels of IgG2a than resistant mice during infection (3) and their lymphocytes are capable of IFN-qr production during restimulation with borrelial antigens (9) . Comparable data regarding T helper cytokines produced by resistant mice (or asymptomatic infected humans) had not been available.
We demonstrate that Borrelia-specific lymphokine patterns underlie the host genetic control of this infectious disease: lymphocytes from susceptible C3H/HeJ mice produce high levels of IFN-3, and low levels of Ib4 when restimulated with borrelial sonicates, and neutralization of IFN-3~ during infection attenuated the initial severity of proximal arthritis. Antigen-stimulated lymphocytes from resistant BALB/c mice produced high levels of Ib4 with much lower levels of IFN-3, and neutralization of Ib4 in vivo significantly enhanced early disease severity. The current study employed bulk lymphoid populations but we infer that the cellular sources of these lymphokines are T helper cells. During restimulation with antigen, only culture wells which exhibited vigorous clonal expansion characteristic of lymphocytes had significant production of lymphokines (Reiner, S., unpublished results). Since B cells do not produce II_-4 and IFN-% we believe their sources are CD4 + T cells, a conclusion supported by other murine infectious disease models with demonstrable polarization in IL-4 and IFN-y production derived from CD4 + T cells (5-7). Whereas NK (or CD8 + T) cells may produce IFN-qr and basophils (or mast cells) may produce IL-4, their contribution to the polarized lymphokine phenotypes in this model is still being investigated.
To focus and amplify the immune response, we modified experimental Lyme disease by inoculating the spirochete distal to an easily visualized joint and a draining lymph node. Our model of localized Lyme arthritis faithfully reproduces the genetic and pathological differences found using intraperitoneal or intradermal (nonfootpad) infection (2, 3, 10) although inoculation at other sites has yet to reveal a difference in the quality of the T cell response between susceptible and resistant hosts (3, 9, 11) . The dramatic lymphokine polarization we observe would not have been detected without analyzing a proximal lymph node since the responses were essentially absent in the distant lymph node and spleen. Although disease is often attenuated in the left ankle and we are unsure whether carditis is present at all, the proximal arthritis provides an extremely useful model for the immunologic basis of susceptibility since the inability to control centripetal dissemination is under the same genetic regulation as the severity of distal arthritis and carditis (12) .
The immunoprotective or immunopathologic mechanisms that the T helper subsets might mediate during this infection will require further analysis. Pathologic severity in mice has been linked with persistence of spirochete DNA in tissues (4) and spirochete DNA has been detected in the joints of humans with Lyme disease (D), indicating that control of the microbial burden is necessary (if not sufficient) to prevent the severe pathological changes associated with this infection. The ability to passively transfer protection to scid mice with an anti-OspA (a major surface protein of the spirochete) mAb (14) and protect C3H mice with recombinant OspA immunization (15) or passive transfer of human immune sera (16) suggests that effective humoral responses could be sufficient for protective immunity. The finding of higher Ib4 production, a B cell stimulatory factor, in resistant mice, is consistent with a protective role for humoral immunity. Although infected C3H/HeJ mice exhibit higher serum IgG levels than BALB/c mice (2, 3), our results suggest that secondary sampling sites may be misleading in detecting primary immunoregulatory events and that higher serum IgG may merely be an index of progressive disease. We, in contrast, observe increased B-to-T cell ratios in the right popliteal nodes of resistant BALB/c versus C3H/HeJ mice which were not evident in the left nodes and spleens (Reiner, S., unpublished results).
The production of Thl-type cytokines by susceptible mice may represent a deficiency in protective immunity but could also be immunopathologic. Consistent with our finding of higher IFN-3, production, infected C3H/HeJ mice exhibit marked increase in serum IgG2a (3). This IFN-3,-induced isotype fixes complement and binds Fc'/RI on monocytes with high affinity, perhaps inducing complement-or monokinemediated tissue damage, as has been proposed by others (3, 9) . Further clarification of the protective nature of a Th2 response or the exacerbative nature of a Thl response in Lyme disease should help explain many of the unresolved features of its pathogenesis. Subsequent analysis should be greatly facilitated using the current modification of experimental Lyme borreliosis which illuminates critical genetic differences in immune regulation.
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